Showing 401 - 420 results of 31,796 for search '(( 5 ((fold decrease) OR (point decrease)) ) OR ( 100 ((nm decrease) OR (a decrease)) ))', query time: 0.78s Refine Results
  1. 401

    Supplementary Material for: Platelet Decreases following Continuous Renal Replacement Therapy Initiation as a Novel Risk Factor for Renal Nonrecovery by Griffin B.R. (8570007)

    Published 2021
    “…<b><i>Conclusions:</i></b> Platelet nadir <100 × 10<sup>3</sup>/µL and platelet decrease by >50% following CRRT initiation were both associated with lower rates of renal recovery. …”
  2. 402
  3. 403
  4. 404
  5. 405
  6. 406
  7. 407
  8. 408
  9. 409
  10. 410
  11. 411
  12. 412
  13. 413
  14. 414
  15. 415

    Belinostat decreases both male and female bladder weights in transgenic superficial bladder cancer mice by Michael T Buckley (37161)

    Published 2011
    “…Normal non-transgenic mouse bladders weigh approximately 10.0 mg at the same age, and Ha-transgenic mice with superficial bladder cancer have a 3 fold and higher bladder weight. , Male belinostat-treated mice (n = 4, 327.5 mg average weight) showed a two-fold decrease (50%, p = 0.03) in bladder weight versus control (n = 4, 652.5 mg average weight). , Female belinostat-treated mice (n = 5, 34.0 mg average weight) showed a 36% decrease (p = 0.04) in bladder weight versus control (n = 6, 53.3 mg average weight).…”
  16. 416
  17. 417
  18. 418

    S100A4 inhibits cell proliferation by interfering with the S100A1-RAGE V domain - Fig 2 by Md. Imran Khan (4853302)

    Published 2019
    “…The cross peaks, which exhibited decreased intensity, are boxed in green. (B) Ribbon diagram showing the structure of S100A1—decreasing residues are labeled on the structure in green.…”
  19. 419

    S100A4 inhibits cell proliferation by interfering with the S100A1-RAGE V domain - Fig 1 by Md. Imran Khan (4853302)

    Published 2019
    “…(B) Ribbon diagram showing the structure of S100A4; intensity decreasing residues are labeled on the structure in cyan.…”
  20. 420